Lavelle Erin
Director at NGNE; Chief Operating Officer at ALDER BIOPHARMACEUTICALS INC
- Sold, on record
- $20k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Apr 25, 2019
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- NGNENeurogene Inc.Director
- ALDER BIOPHARMACEUTICALS INCChief Operating Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ALDER BIOPHARMACEUTICALS INCPlan not statedApr 25, 2019 2019
Sold 1,434 shares at $13.67 ($20k)
Lavelle Erin, Chief Operating Officer
Sold 24.5% of holdings ($80k position)4,408 shares leftFirst sale on recordFiling
- 2 Form 144 notice NGNENoticeFeb 6, 2024 +1748 days
Filed to sell 2,500 shares ($76k)
Lavelle Erin, Director
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Feb 6, 2024 | NGNE | Director | Form 144 notice | 2,500 | $76k | Notice | SEC | |
| Apr 25, 2019 | Apr 25, 2019 | ALDER BIOPHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 1,434 | $20k | 24.5% | Plan not stated | SEC |